Jubilant Pharmova Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2026 ,inter alia, to consider and approve the Un-audited Standalone ....

August 05, 2026 BSE Limited National Stock Exchange of India Limited Floor 25, P. J. Towers Exchange Plaza Dalal Street, Fort Bandra Kurla Complex, Bandra (E) Mumbai - 400 001 Mumbai - 400 051 Scrip Code: 530019 Symbol: JUBLPHARMA Sub: Intimation of Postponement and Rescheduling of Board Meeting Scheduled for August 10, 2026 Dear Sirs, This is in continuation of our earlier announcement dated July 30, 2026 and pursuant to the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. We wish to inform you that, due to unavoidable circumstances, the meeting of the Board of Directors of the Company scheduled to be held on Friday, August 7, 2026, inter alia, to consider and approve the Un-audited Standalone and Consolidated Financial Results of the Company for the quarter ended June 30, 2026, has been postponed and rescheduled to Monday, August 10, 2026. Further, the trading window for dealing in the securities of the Company has remained closed from Wednesday, July 01, 2026 and shall continue to remain closed until Wednesday, August 12, 2026 (both days inclusive) for the designated persons and their immediate relatives, in accordance with the Company’s Code of Conduct framed pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended. The designated persons of the Company have been informed accordingly. This intimation will also be made available on the Company’s website at www.jubilantpharmova.com. This is for your information and record. Thanking you, Yours faithfully, For Jubilant Pharmova Limited Naresh Kapoor Company Secretary